YKL-40, CCL18 and SP-D predict mortality in patients hospitalized with community-acquired pneumonia

Association of Serum YKL-40 With the Presence and Severity of Obstructive Sleep Apnea Syndrome

(2015) Wei Li et al.   Labmedicine

The Evaluation of Serum Surfactant Protein D (SP-D) Levels as a Biomarker of Lung Injury in Tuberculosis and Different Lung Diseases

(2014) Aygül Güzel et al.   Clinical Laboratory

YKL-40 Is Elevated in Patients with Chronic Obstructive Pulmonary Disease and Activates Alveolar Macrophages

(2014) S. Letuve et al.   JOURNAL OF IMMUNOLOGY

Serum Surfactant Protein D (SP-D) is a Prognostic Marker of Poor Outcome in Patients with A/H1N1 Virus Infection

(2014) Carlos Delgado et al.   LUNG

Evaluation of Circulating YKL-40 Levels in Idiopathic Interstitial Pneumonias

(2014) Nicoline M. Korthagen et al.   LUNG

Serum YKL-40 concentrations are elevated and correlated with disease severity in patients with obstructive sleep apnea syndrome

(2014) Xin Wang et al.   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION

Plasma YKL-40 and CHI3L1 in systemic inflammation and sepsis—Experience from two prospective cohorts

(2013) Brian Kornblit et al.   IMMUNOBIOLOGY

Usefulness of Plasma YKL-40 in Management of Community-Acquired Pneumonia Severity in Patients

(2013) Hsiang-Ling Wang et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Predictive Values of Semi-Quantitative Procalcitonin Test and Common Biomarkers for the Clinical Outcomes of Community-Acquired Pneumonia

(2013) M. Ugajin et al.   Respiratory Care

Differential alveolar epithelial injury and protein expression in pneumococcal pneumonia

(2012) Christine Tyrrell et al.   EXPERIMENTAL LUNG RESEARCH

Pulmonary CCL18 Recruits Human Regulatory T Cells

(2012) C. Chenivesse et al.   JOURNAL OF IMMUNOLOGY

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

(2012) Rafael Lozano et al.   LANCET

The Significance of Elevated Tumor Markers Among Patients With Idiopathic Pulmonary Fibrosis Before and After Lung Transplantation

(2011) Victoria Rusanov et al.   CHEST

Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial

(2011) Sabine CA Meijvis et al.   LANCET

Cause‐specific long‐term mortality rates in patients recovered from community‐acquired pneumonia as compared with the general Dutch population

(2010) A.H.W. Bruns et al.   CLINICAL MICROBIOLOGY AND INFECTION

Serum and BALF YKL-40 levels are predictors of survival in idiopathic pulmonary fibrosis

(2010) Nicoline M. Korthagen et al.   RESPIRATORY MEDICINE

Serum CC-Chemokine Ligand 18 Concentration Predicts Outcome in Idiopathic Pulmonary Fibrosis

(2009) Antje Prasse et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Recognition of Mannosylated Ligands and Influenza A Virus by Human Surfactant Protein D: Contributions of an Extended Site and Residue 343†,‡

(2009) Erika Crouch et al.   BIOCHEMISTRY